166 related articles for article (PubMed ID: 19434321)
1. Crohn disease or intestinal fistulising tuberculosis? Diagnosis difficulties in a case treated with infliximab and corticosteroids.
Cazacu S; Vere CC; Comănescu V; Dumitrescu C; Enache SD; Ciurea T
Rom J Morphol Embryol; 2009; 50(2):263-8. PubMed ID: 19434321
[TBL] [Abstract][Full Text] [Related]
2. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
[TBL] [Abstract][Full Text] [Related]
3. [Corticosteroid refractory colonic Crohn disease with successful remission with infliximab].
Alva E; Vásquez J; Frisancho O; Mantilla L; Yábar A; Morales D
Rev Gastroenterol Peru; 2009; 29(1):51-4. PubMed ID: 19424409
[TBL] [Abstract][Full Text] [Related]
4. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Van Assche G; Dignass A; Reinisch W; van der Woude CJ; Sturm A; De Vos M; Guslandi M; Oldenburg B; Dotan I; Marteau P; Ardizzone A; Baumgart DC; D'Haens G; Gionchetti P; Portela F; Vucelic B; Söderholm J; Escher J; Koletzko S; Kolho KL; Lukas M; Mottet C; Tilg H; Vermeire S; Carbonnel F; Cole A; Novacek G; Reinshagen M; Tsianos E; Herrlinger K; Oldenburg B; Bouhnik Y; Kiesslich R; Stange E; Travis S; Lindsay J;
J Crohns Colitis; 2010 Feb; 4(1):63-101. PubMed ID: 21122490
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
6. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Rutgeerts P; Van Assche G; Vermeire S
Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
[TBL] [Abstract][Full Text] [Related]
7. Infliximab in fistulizing Crohn's disease.
Osterman MT; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
[TBL] [Abstract][Full Text] [Related]
8. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
9. Rapid recovery of a rectovaginal fistula with infliximab in a patient with Crohn's disease.
Hagiu C; Badea R; Serban A; Petrar S; Andreica V
J Gastrointestin Liver Dis; 2010 Sep; 19(3):329-32. PubMed ID: 20922201
[TBL] [Abstract][Full Text] [Related]
10. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
Keane J; Gershon S; Wise RP; Mirabile-Levens E; Kasznica J; Schwieterman WD; Siegel JN; Braun MM
N Engl J Med; 2001 Oct; 345(15):1098-104. PubMed ID: 11596589
[TBL] [Abstract][Full Text] [Related]
12. Review article: Medical therapy for fistulizing Crohn's disease.
Bressler B; Sands BE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF treatment and miliary tuberculosis in Crohn's disease.
Milenković B; Dudvarski-Ilić A; Janković G; Martinović L; Mijac D
Srp Arh Celok Lek; 2011; 139(7-8):514-7. PubMed ID: 21980664
[TBL] [Abstract][Full Text] [Related]
14. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
15. The management of fistulizing oral Crohn's disease with infliximab.
Staines KS; Green R; Felix DH
J Oral Pathol Med; 2007 Aug; 36(7):444-6. PubMed ID: 17617840
[TBL] [Abstract][Full Text] [Related]
16. Development of miliary tuberculosis under infliximab in a patient with spondyloarthritis and suspected Crohn's disease.
Koschny R; Junghanss T; Mischnik A; Karner M; Kreuter M; Roth W; Stremmel W; Merle U
Z Gastroenterol; 2013 Oct; 51(10):1177-83. PubMed ID: 24122379
[TBL] [Abstract][Full Text] [Related]
17. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.
Arend SM; Leyten EM; Franken WP; Huisman EM; van Dissel JT
Clin Infect Dis; 2007 Dec; 45(11):1470-5. PubMed ID: 17990230
[TBL] [Abstract][Full Text] [Related]
18. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B
Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424
[TBL] [Abstract][Full Text] [Related]
19. Rheumatic fever in a patient receiving infliximab therapy for Crohn disease.
Abu-El-Haija M; Stasheff S; Atkins DL; Bishop WP
J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):360-1. PubMed ID: 21150656
[No Abstract] [Full Text] [Related]
20. [Disseminated tuberculosis following infliximab therapy for Crohn disease: a case report].
Bouchentouf R; Yasser Z; Aitbenasser MA
Rev Pneumol Clin; 2014 Dec; 70(6):366-9. PubMed ID: 25131370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
